Turnstone Biologics Corporation (TSBX) - Company Cash Volume

Official company branding of Turnstone Biologics Corp (TSBX)

Cancer immunotherapy development is proceeding within a secure jurisdiction supported by stable international cooperation. Turnstone Biologics (TSBX) relies on lymphocyte selection to combat solid tumors while striving for pricing leadership. However, the costs of personalized manufacturing and testing uncertainties create risks. The cash structure on this GURU.Markets platform chart is fixed at 0.02, confirming current financial stability.

TSBX - turnstonebio.com Company Cash Reserve over the range 02/21/2024 - 08/24/2025

Analytical breakdowns for Turnstone Biologics

- current price and projected stock value:
Fundamental company valuation:Turnstone Biologics Corp. TSBX
Brand item of Turnstone Biologics

This indicator reflects the dynamics of liquid assets, allowing for an assessment of capital management efficiency and the rate of cash burn. By analyzing the history of cash volume changes, an investor determines the stability of the company's financial reserve. The metric measures the balance between resource accumulation and operational expenditure. For Turnstone Biologics (TSBX), this is critical due to the high cost of cell therapy trials. Monitoring cash balances ensures uninterrupted biomaterial logistics under high-risk conditions.

Competitors of Turnstone Biologics (TSBX)

Company Cash on Hand IBRX (ImmunityBio Corp)|Company Total Cash Amount IMCR|Company Cash Volume JANX (Janux Therapeutics, Inc.)|Company Cash Balance RCUS|zymeworks.com - Company Cash Volume|Company Cash Reserve Tango Therapeutics Corp|Iovance Biotherapeutics (IOVA) - Company Cash Funds|Immatics N.V. - Company Cash Balance|XNCR (xencor.com) - Company Cash Volume|Company Cash Volume Compass Therapeutics Inc|Company Cash Funds Replimune (REPL)|LYEL: Company Total Cash Volume|Innate Pharma SA - Company Cash on Hand|Pyxis Oncology, Inc. (PYXS) - Company Cash Reserve|Compugen - Company Cash Volume|Company Liquid Assets IO Biotech Inc IOBT|STRO (Sutro Biopharma Inc.) - Company Cash on Hand|INKT - Company Liquid Assets|Company Cash Funds werewolftx.com|Company Cash on Hand Immix Biopharma, Inc. (IMMX)|Company Cash on Hand ALXO (ALX Oncology Holdings)|Company Cash Funds CUE (Cue Biopharma)|Company Cash Volume PDSB (PDS Biotechnology Corp)|sonnetbio.com (SONN) - Company Cash Reserve|MAIA Biotechnology - Company Cash Volume|LIMN - Company Cash Volume|LVTX: Company Cash Volume|NextCure - Company Cash Balance|LPTX (Leap Therapeutics Inc) - Company Cash Volume|INTS (Intensity Therapeutics, Inc.) - Company Total Cash Amount|Company Cash Volume SNSE|Company Cash Funds TOVX (Theriva Biologics, Inc.)|Gritstone bio, Inc. - Company Cash on Hand|Company Cash Volume Kineta KA|NexImmune Corporation - Company Cash Volume|VCNX (Vaccinex, Inc) - Company Cash and Cash Equivalents|Harpoon Therapeutics (HARP) - Company Cash Funds